Home
>
National Drug Code (NDC)
>
OXALIPLATIN
OXALIPLATIN - 0069-1010-01 - (OXALIPLATIN)
Drug Information of OXALIPLATIN
| Product NDC: | 0069-1010 |
| Proprietary Name: | OXALIPLATIN |
| Non Proprietary Name: | OXALIPLATIN |
| Active Ingredient(s): | 100 mg/20mL & nbsp; OXALIPLATIN |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of OXALIPLATIN
| Product NDC: | 0069-1010 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200979 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120809 |
Package Information of OXALIPLATIN
| Package NDC: | 0069-1010-01 |
| Package Description: | 20 mL in 1 VIAL (0069-1010-01) |
NDC Information of OXALIPLATIN
| NDC Code | 0069-1010-01 |
| Proprietary Name | OXALIPLATIN |
| Package Description | 20 mL in 1 VIAL (0069-1010-01) |
| Product NDC | 0069-1010 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | OXALIPLATIN |
| Dosage Form Name | POWDER, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120809 |
| Marketing Category Name | ANDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc. |
| Substance Name | OXALIPLATIN |
| Strength Number | 100 |
| Strength Unit | mg/20mL |
| Pharmaceutical Classes | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
